RICHMOND, VA - (ACCESSWIRE - August 12, 2013 )- avVaa World Health Care Products ("the Company") ("avVaa" or "the Company") (OTC Pink: AVVH)
avVaa World Health Care Products Inc. (http://www.avvaa.com/) has successfully negotiated the rights to the trademark 'Neuroskin' with our inventor in Germany and now own the registered trademark 'Neuroskin'. This opens the doors not only to protect the existing avVaa line of Neuroskin products, it also allows development of additional products under the brand name Neuroskin. "We are pleased to have negotiated the acquisition of the Neuroskin trademark and will continue to look for additional ways to add value for our shareholders," said Jason Price, Chairman and CEO of avVaa.
avVaa World Health Care Products Inc. (http://www.avvaa.com/) has successfully completed the Natural Health Canada product registration for Neuroskin Psoriasis, Acne and Itch Relief. "This will enable the company to sell Neuroskin products into the Canadian Drugstores, Natural Product Health Stores and other retailers who want a line of natural products that treat skin conditions that are approved under the Health Canada Natural Products Act," said Jason Price, Chairman and CEO of avVaa. Presentation Kits are presently under development for presentation to retailers across Canada.
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R) line of skin care products through mass food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: http://www.avvaa.com/.
This news release contains statements which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of avVaa World Health Care Products, and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
Jason Price Chairman & CEO
avVaa World Health Care Products
Pink Sheets: AVVH
SOURCE: avVaa World Health Care Products Inc.
Leave a comment...